Background Image
Menu

News: 2025

AgTech startup CroBio raises €850k to reshape agriculture through enhanced microbes

12 February 2025

AgTech startup CroBio raises €850k to reshape agriculture through enhanced microbes

Cheshire-based CroBio, an AgTech startup on a mission to reshape the future of agriculture by harnessing the power of enhanced microbes, announced €805k in new funding to enhance their living soil amendment, a technology designed to improve nutrient retention, water retention...

Monument Therapeutics announces grant of Chinese patent in support of its MT1988 cognitive impairment associated with schizophrenia program.

21 January 2025

Monument Therapeutics announces grant of Chinese patent in support of its MT1988 cognitive impairment associated with schizophrenia program.

Manchester, UK, 21 January 2025 - Monument Therapeutics, a stratified medicine company developing novel treatments for areas of high unmet need in psychiatry and neurology, today announced that the China National Intellectual Property Administration (“CNIPA”) has granted Chinese...

Monument Therapeutics announces grant of Japanese patent in support of its MT1988 cognitive impairment associated with schizophrenia program

14 January 2025

Monument Therapeutics announces grant of Japanese patent in support of its MT1988 cognitive impairment associated with schizophrenia program

Manchester, UK, 14 January 2025 - Monument Therapeutics, a stratified medicine company developing novel treatments for areas of high unmet need in psychiatry and neurology, today announced that the Japan Patent Office (“JPO”) has granted Japanese patent 7570345, in support of...

Boehringer Ingelheim acquires fourth license for the development of novel antibody based cancer treatments from Oxford BioTherapeutics

13 January 2025

Boehringer Ingelheim acquires fourth license for the development of novel antibody based cancer treatments from Oxford BioTherapeutics

Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based therapies, today announced that Boehringer Ingelheim has exercised an option for...

Maxwellia announces strategic leadership appointments to propel future growth

7 January 2025

Maxwellia announces strategic leadership appointments to propel future growth

Alderley Park, Cheshire, UK – Monday 6 January 2025 – Maxwellia, the female founded pioneering consumer healthcare company, is pleased to announce two significant additions to its leadership team. Candice Brett has been appointed as Chief Financial Officer (CFO), and Colin...